Radiation therapy concurrent with weekly cisplatin therapy for loco-regionally advanced nasopharyngeal carcinoma: outcomes of a clinical trial

By Ma Daiyuan   Fu Chunqiao   Tan Bangxian   Liu Mi   Li Xianfu   Zhou Yeqin  

The Chinese-German Journal of Clinical Oncology, Vol. 10, Iss. 4, 2011-04 ,pp. : 187-191

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of concurrent chemoradiotherapy with S1 versus weekly cisplatin for locoregionally advanced nasopharyngeal carcinoma

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 687-691

Science Publishers

Access to resources Recommend Favorite

Competing causes of death in patients with locoregionally advanced head and neck cancer treated with concomitant boost radiation plus concurrent weekly cisplatin

By Gómez-Millán Jaime  

Clinical and Translational Oncology, Vol. 15, Iss. 4, 2013-04 ,pp. : 321-326

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy

By                              

Oncology Reports, Vol. 27, Iss. 5, 2012-01 ,pp. : 1580-1586

Spandidos Publications

Access to resources Recommend Favorite

Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma

By      

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 1123-1130

Spandidos Publications

Access to resources Recommend Favorite